TYK2 inhibitor (Bristol-Myers Squibb)

N/A

Report date: 2025/06/11 10:55:05
NME

Base Information

Drug NameTYK2 inhibitor (Bristol-Myers Squibb)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionTyrosine-protein kinase 2 inhibitorsNeuroprotectants
TargetsTyrosine-protein kinase 2
Therapy Area/IndicationsCentral Nervous System DiseasesMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesBristol-Myers Squibb Company
Inactive CompaniesN/A
Active IndicationsCentral Nervous System DiseasesMultiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A